Bicycle Therapeutics (BCYC) Asset Utilization Ratio (2019 - 2026)
Bicycle Therapeutics' (BCYC) quarterly Asset Utilization Ratio came in at 0.1 in Q2 2026, up 332.69% YoY from 0.02 in Q2 2025, and up 4.89% on a QoQ basis from 0.09 in Q1 2026.
Analysis
Bicycle Therapeutics (BCYC) Asset Utilization Ratio (2019 - 2026) Analysis & Trends
Bicycle Therapeutics (BCYC) has 8 years of Asset Utilization Ratio data on file, last reported at 0.1 in Q2 2026.
- Quarterly Asset Utilization Ratio rose 332.69% year-over-year to 0.1 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.1 (up 332.69% YoY) and the FY2025 annual result came in at 0.09, up 90.75% from the prior year.
- Asset Utilization Ratio rose to 0.1 in Q2 2026, from 0.09 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.1 in Q4 2025 to a low of 0.02 in Q2 2025.
- A 5-year average of 0.05 and a median of 0.04 in 2023 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio slumped 57.13% — and 2026, when it jumped 332.69%.
- Tracing BCYC's Asset Utilization Ratio over 5 years: stood at 0.06 in 2022, then fell by 23.65% to 0.04 in 2023, then slumped by 38.78% to 0.03 in 2024, then jumped by 266.09% to 0.1 in 2025, then fell by 0.77% to 0.1 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.1 (Q2 2026), 0.09 (Q1 2026), and 0.1 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 0.20 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 0.69 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 0.90 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.13 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 0.54 |
| 10 | Bicycle Therapeutics | 299.81 Mn | 299.81 Mn | - | 0.10 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.10 |
| Mar 31, 2026 | 0.09 |
| Dec 31, 2025 | 0.10 |
| Sep 30, 2025 | 0.04 |
| Jun 30, 2025 | 0.02 |
| Mar 31, 2025 | 0.03 |
| Dec 31, 2024 | 0.04 |
| Sep 30, 2024 | 0.04 |
| Jun 30, 2024 | 0.05 |
| Mar 31, 2024 | 0.07 |
| Dec 31, 2023 | 0.04 |
| Sep 30, 2023 | 0.05 |
| Jun 30, 2023 | 0.06 |
| Mar 31, 2023 | 0.06 |
| Dec 31, 2022 | 0.06 |
| Sep 30, 2022 | 0.04 |
| Jun 30, 2022 | 0.04 |
| Mar 31, 2022 | 0.02 |
| Dec 31, 2021 | 0.03 |
| Sep 30, 2021 | 0.05 |